Global Dermatphytosis Treatment Market Snapshot:
Dermatophytosis is an infectious disease caused by fungi known as dermatophytes. This fungus belongs to a family of organisms that can break down the keratin in epidermis, nails, horns and hooves, epidermis and nails. These fungi, which mainly thrive in the soil and are involved in soil degradation, can also infect living hosts.
Receive an exclusive PDF sample copy of this report: https://www.tmrresearch.com/sample/sample?flag=B&rep_id=16
Dermatophytosis treatment has unique properties. First, the disease is only present on the keratin of the skin and feeds on keratin for nourishment. However, the presence of the fungus on the skin and its metabolic products causes an allergic reaction in the host. It can affect many body parts. This includes the scalp, groin, feet, bearded skin of the face and nails. The symptoms of dermatophytosis range from mild inflammation to severe vesicular reactions.
Dermatophytosis develops either through direct contact with infected wounds or indirectly through infected towels, shoes, or shower cubicles. The combination of slightly warm weather and tight clothing is conducive to the blooming of the fungus.
Topical antifungal creams such as clotrimazole, miconazole, and terbinafine are effective for treating simple forms of dermatophytosis located in areas other than the scalp. Treatment involves cleaning the affected area and thoroughly rubbing cream onto the skin.
If the nature of the disease is severe, a prescribed line of treatment is required. This includes prescription drugs and home care to keep the infection from spreading. Home care includes avoiding clothing that makes the infected area uncomfortable, cleaning and drying the skin regularly, and washing bedding and clothing daily until the infection is completely gone.
Global Dermatphytosis Treatment Market: Overview:
Dermatophytosis is a fungal infection of the skin caused by a fungus that feeds on keratin, a material found in the outer layer of the skin, nails, and hair. Dermatophytosis is commonly referred to as ringworm and affects both humans and animals.
Common symptoms of dermatophytosis include itching, redness and dryness of the infected area, separation of the nail from the nail bed, scaling, nail dystrophy, broken hair, hair loss, rashes, and nail discoloration. People with weak immune systems and those who play contact sports are at a higher risk of dermatophytosis. The skin condition is known to worsen in the summer with increased symptoms in the winter.
Buy this report @ https://www.tmrresearch.com/checkout?rep_id=16
Global Dermatophytosis Treatment Market Segmentation:
Based on the diagnosis, the global dermatophytosis treatment market is classified into wood test, microscopic test, culture test and others. By used drugs, the market has been segmented into imidazole, econazole, clotrimazole, miconazole, ketoconazole, terbinafine, clotrimazole, corticosteroid, terbinafine, itraconazole, griseofulvin and others. Geographically, the dermatophytosis treatment market is segmented into North America, Europe, Asia-Pacific, and Rest of the World (RoW).
Dermatphytosis Treatment Market: Drivers and Constraints
One of the main factors driving the need for dermatophytosis treatment is an increasing population of people with weak immune systems. The immune system weakens with age and a globally increasing geriatric population, contributing to the high prevalence of dermatophytosis. Apart from this, the increasing sedentary lifestyle and the increasing incidence of hospital-acquired diseases have led to a higher rate of dermatophytosis. This has boosted the demand for dermatophytosis treatment.
On the other hand, the lack of awareness about dermatophytosis and related diseases, and their treatment options, limits the growth prospects of this market. Moreover, the reluctance of patients to receive dermatophytosis treatment is inhibiting the global growth of the market.
Global Dermatphytosis Treatment Market: Geographical Assessment:
From a geographic point of view, North America currently dominates the global dermatophytosis treatment market, with Europe in second place. Favorable reimbursement coverage, the availability of a highly developed healthcare infrastructure, a high level of awareness regarding dermatophytosis, increased health care expenditures, the availability of advanced healthcare facilities and a greater awareness of the benefits of early diagnosis and treatment of dermatophytosis are some of the most important factors are driving the markets in North America and Europe for the treatment of dermatophytosis.
Asia-Pacific has high growth potential in the global dermatophytosis treatment market and is likely to make strong progress in the near future. Rapidly rising literacy rates, improving healthcare infrastructure, increasing government support to improve healthcare facilities, and rising healthcare spending are some of the key drivers in the Asia-Pacific region. The dermatophytosis treatment market in India and China is expected to grow rapidly due to the rapidly developing medical tourism in these countries. Japan is also expected to contribute to the expansion of the dermatophytosis treatment market in Asia, with the government focusing more on providing improved and advanced healthcare facilities to its citizens.
Brazil, Mexico and Argentina are some of the key countries in the Rest of the World (RoW) segment that are expected to show promising growth in the dermatophytosis treatment market.
Global Dermatophytosis Treatment Market: Major Contributors:
There are a number of players active in the global dermatophytosis treatment market. These include Novartis AG, Quinnova Pharmaceuticals, Inc., Sun Pharmaceutical Industries Limited, Tinea Pharmaceuticals, NB Therapeutics, Inc., AmDerma Pharmaceuticals, LLC, Valeant Pharmaceuticals International, Inc., Merz Pharma GmbH & Co. KgaA, Perrigo Company plc. In addition, several research institutes and universities are collaborating with drug manufacturers to conduct clinical trials to develop effective treatment methods for dermatophytosis. Some of the major contributors include the University of Minnesota, Karolinska Institute, Catholic University of Leuven, Eastern Virginia Medical School, Kurdistan University of Medical Sciences, the Department of Health, South Africa, Jamaica Hospital Medical Center, the University of Alabama at Birmingham, The Children’s Mercy Hospital and Oita University.
For more information about the table of contents, click @ https://www.tmrresearch.com/sample/sample?flag=T&rep_id=16
About TMR research
TMR Research is a premier provider of tailor-made market research and advisory services to business entities eager to succeed in today’s supercharged economic environment. Armed with an experienced, dedicated and dynamic team of analysts, we are redefining the way our clients do business by providing them with authoritative and reliable research studies in line with the latest methodologies and market trends.